Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder

Addictive Behaviors

Volumn 34, Issue 10, 2009, Pages 905-909

  Cornelius, Jack R ^a   Bukstein, Oscar G ^a   Wood, D Scott ^a   Kirisci, Levent ^a   Douaihy, Antoine ^a   Clark, Duncan B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescents; Alcohol use disorder; Antidepressants; Comorbid; Major depression

Indexed keywords

ALCOHOL; FLUOXETINE; PLACEBO;

ADOLESCENT; ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; MALE; MOTIVATION; RANDOMIZED CONTROLLED TRIAL; SUICIDAL IDEATION; SYMPTOM;

ADOLESCENT; ADOLESCENT BEHAVIOR; ALCOHOL-RELATED DISORDERS; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MOTIVATION; PENNSYLVANIA; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 67651108883     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2009.03.008     Document Type: Article

References (37)

1. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 4 (1961) 561-571
2. Birmaher B., Brent D.A., Kolko D., Baugher M., Bridge J., Holder D., et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Archives of General Psychiatry 57 (2000) 29-36
3. Blazer D.G., Kessler R.C., McGonagle K.A., and Swartz M.S. The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. The American Journal of Psychiatry 151 7 (1994) 979-986
4. Brent D.A., Holder D., Kolko D., Birmaher B., Baugher M., Roth C., et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry 54 (1997) 877-885
5. Bukstein O.G., Glancy L.J., and Kaminer Y. Pattern of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. Journal of the American Academy of Child and Adolesccent Psychiatry 31 (1992) 1041-1045
6. Cornelius J.R., Bukstein O.G., Birmaher B., Salloum I.M., Lynch K., Pollock N.K., et al. Fluoxetine in adolescents with major depression and an alcohol use disorder: An open-label trial. Addictive Behaviors 26 (2001) 735-739
7. Cornelius J.R., Bukstein O.G., Salloum I.M., Kelly T.M., Wood D.S., and Clark D.B. Fluoxetine in depressed AUD: A one-year follow-up evaluation. Journal of Child and Adolescent Psychopharmacology 14 (2004) 35-40
8. Cornelius J.R., Clark D.B., Bukstein O.G., Birmaher B., Salloum I.M., and Brown S.A. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: A review. Addictive Behaviors 30 (2007) 1824-1833
9. Cornelius J.R., Salloum I.M., Ehler J.G., Jarrett P.J., Cornelius M.D., Perel J.M., et al. Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Archives of General Psychiatry 54 (1997) 700-705
10. Emslie G.J., Heiligenstein J.H., Wagner K.D., Hoog S.L., Ernest D.E., Brown E., et al. Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry 41 (2002) 1205-1215
11. Emslie G.J., Kennard B.D., Mayes T.L., Nightingale-Teresi J., Carmody T., Hughes C.W., et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. American Journal of Psychiatry 165 (2008) 459-467
12. Emslie G.J., Rush A.J., Weinberg W.A., Kowatch R.A., Hughes C.W., Carmody T., et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 54 (1997) 1037
13. Festinger D.S., Marlowe D.B., Dugosh K.L., Croft J.R., and Arabia P.L. Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion. Drug and Alcohol Dependence 96 (2008) 128-135
14. Grant B.F., Dawson D.A., Stinson F.S., Chou S.P., Dufour M.C., and Pickering R.P. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug and Alcohol Dependence 74 (2004) 223-234
15. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23 (1960) 56-62
16. Jain U., Birmaher B., Garcia M., Al-Shabbout M., and Ryan N. Fluoxetine in children and adolescents with mood disorders: A chart review of efficacy and adverse events. Journal of Child and Adolescent Psychopharmacology 2 (1992) 259-265
17. Kadden R., Carroll K.M., Donovan D., Cooney N., Monti P., Abrams D., et al. Cognitive-behavioral coping skills therapy manual: A clinical Research Guide for therapists treating individuals with alcohol abuse and dependence. Project MATCH Monograph Series Vol. 5 (1994), NIAAA, Rockville, MD DHHS Publication No. 96-4004
18. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 36 (1997) 980-988
19. Kessler R.C., and Walters E.E. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depression and Anxiety 7 (1998) 3-14
20. Klein R.G., Mannuzza S., Koplewicz H.S., Tancer N.K., Shah M., Liang V., et al. Adolescent depression: Controlled desipramine treatment and atypical features. Depression and Anxiety 7 (1998) 15-31
21. Kosten T.A., and Rounsaville B.J. Sensitivity of psychiatric diagnosis based on the best estimate procedure. American Journal of Psychiatry 149 (1992) 1225-1227
22. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., and Weissman M.M. Best estimate of lifetime psychiatric diagnosis: A methodological study. Archives of General Psychiatry 39 (1982) 879-883
23. March J.S., Silva S.G., Compton S., Anthony G., DeVeaugh-Geiss J., Califf R., et al. The Child and Adolescent Psychiatry Trials Network (CAPTN). Journal of the American Academy of Child and Adolescent Psychiatry 43 5 (2004) 515-518
24. Martin C.S., Pollock N.K., Bukstein O.G., and Lynch K.G. Inter-rater reliability of the SCID alcohol and substance use disorders section among adolescents. Drug and Alcohol Dependence 59 (2000) 173-176 Erratum in: Drug and Alcohol Dependence, 60, 323
25. Miller W.R., Zweben A., DiClemente C.C., and Rychtarik R.G. Motivational Enhancement Therapy Manual. Project MATCH Monograph Series Vol. 2 (1992), National Institute on Alcohol Abuse and Alcoholism, Washington, DC
26. Norusis M.J. Norusis Statistical Package for the Social Sciences (1992), Mc Graw -Hill, New York, USA
27. Nunes E.V., and Levin F.B. Treatment of depression in patients with alcohol or other drug dependence. A meta-analysis. Journal of the American Medical Association 291 (2004) 1887-1896
28. Puig-Antich J. Biological factors in prepubertal major depression. Pediatric Annals 15 867 (1986) 870-2, 873-4
29. Riddle M.A., King R.A., Hardin M.T., Scahill L., Ort S.I., Chappell P., et al. Behavioral side effects of fluoxetine in children and adolescents. Journal of Child and Adolescent Psychopharmacology 1 (1991) 193-198
30. Riggs P.D., Mikulich-Gilbertson S.K., Davies R.D., Lohman M., Klein C., and Stover S.K. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Archives of Pediatric and Adolescent Medicine 161 (2007) 1026-1034
31. Rohde P., Lewinsohn P.M., and Seeley J.R. Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. Journal of Abnormal Psychology 100 (1991) 214-222
32. Sobell L.C., Sobell M.B., Leo G.I., and Cancilla A. Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. British Journal of Addiction 83 (1988) 393-402
33. Spitzer, R., Williams, B., & Gibbon, M. (1988). Structured clinical interview for the DSM-III-R. New York: New York State Psychiatric Institute, Biometrics Research.
34. Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. Journal of the American Medical Association 292 (2004) 807-820
35. Treatment for Adolescents with Depression Study (TADS) Team. The treatment for adolescents with depression study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry 64 (2007) 1132-1144
36. Willenbring M. NIAAA Update: New findings challenge beliefs about alcohol use disorders. American Academy of Addiction Psychiatry News (2006) 2310-2311
37. Young S.E., Corley R.P., Stallings M.C., Rhee S.H., Crowley T.J., and Hewitt J.K. Substance use, abuse and dependence in adolescence: Prevalence, symptom profiles and correlates. Drug and Alcohol Dependence 68 (2002) 309-323